• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    More On GLAXF



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    • Income Statement
    • Balance Sheet
    • Cash Flow

    GlaxoSmithKline plc (GLAXF)

    -Other OTC
    20.95 Down 0.15(0.71%) May 27, 2:27PM EDT
    ProfileGet Profile for:
    GlaxoSmithKline plc
    980 Great West Road
    Brentford, TW8 9GS
    United Kingdom - Map
    Phone: 44 20 8047 5000
    Website: http://www.gsk.com

    Index Membership:N/A
    Full Time Employees:101,255

    Business Summary 

    GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company’s wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company’s nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc has collaboration agreements with Université de Sherbrooke and Pfizer Inc.; development agreement, and R and D collaboration with Propeller Health; R and D collaboration agreement with Valneva SE; and collaboration and license agreement with Idera pharmaceuticals, Inc. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on GlaxoSmithKline plc

    Key Executives 
    Sir Andrew Philip Witty , 51
    Chief Exec. Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    Mr. Simon P. Dingemans , 52
    Chief Financial Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    Dr. Moncef M. Slaoui Ph.D., 56
    Chairman of Global Vaccines, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee
    Mr. Daniel E. Troy ,
    Sr. VP and Gen. Counsel
    Mr. Philip C. Thomson ,
    Sr. VP of Communications & Gov. Affairs
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.